Cost of continuous glucose monitoring prohibitive for most
Findings released from one of the largest surveys of people with type 1 diabetes (T1D) reveals the cost of managing the condition is resulting in poor health outcomes, including depression. …
Fenofibrate finds fame
Diabetic retinopathy (DR) is the leading cause of preventable blindness of working-age adults in the world.1 In Australia it is one of the top five causes of irreversible blindness among …
Lockdown linked to rise in gestational diabetes
Melbourne lockdowns see gestational diabetes cases rise, while experts warn women are missing out on funded-education and support. COVID lockdowns could be behind an increase seen in the rate of …
Standing by the TGA
Threats, intimidation, harassment and abuse of TGA staff or pharmacists and their staff is “totally unacceptable”, say leading groups Organisations including the Public Health Association of Australia, the RACGP, the …
Shortage woes
Wholesaler portals will likely show zero stock quantity for both Actemra ACTPen autoinjector and pre-filled syringe, even if they are available, said TGA The TGA has provided pharmacists with instructions …
100 years since the discovery of insulin: the roadmap to our next big breakthrough
It’s an exciting time for type 1 diabetes (T1D) research with several big breakthroughs poised to make a significant impact on the lives of people with the disease, writes Dr …
Diabetes Updates
‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 …
Diabetes dynamos
Better pay and referral pathways—along with improved education and training—are desperately needed to help tackle diabetes, say award winning credentialled diabetes educators, consultant pharmacist Kirrily Chambers and registered nurse Jayne …
Diabetes study offers glimmer of hope
New research1 reveals new type 2 diabetes cases falling or stable—offering hope for Australian screening and prevention efforts. The annual rates of new cases of adults diagnosed with type 2 …
Push for placebos ‘driven by myths’
Real treatment will normally provide better outcomes for the patient than use of placebos, researchers argue Placebos have their place by helping to achieve blinding in clinical trials—but there is …
Have you found it easy to find mental health support?
COVID has hit the mental health of Australia’s pharmacists hard, according to a new poll At the time of writing, early three-quarters of respondents to the AJP’s latest poll said …
Sigma manages “growth through challenging times”
Pharmacy brands like-for-like sales up 8.7% in spite of COVID hits, half yearly report shows. Sigma Healthcare has experienced what it describes as “organic growth” across its pharmacy brands and …